Sorry, you need to enable JavaScript to visit this website.

ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine]) Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

Advise patients receiving ATGAM that they will be monitored in a facility equipped and staffed with adequate laboratory and supportive medical resources.

Inform patients that ATGAM may cause serious allergic reactions, infection or abnormal liver or renal function.

Serious Allergic Reactions

  • Advise the patient to discontinue ATGAM and seek immediate medical attention if any signs/symptoms of an allergic or immune reaction occur [see Warnings and Precautions (5.1)].

Skin Testing

  • Despite screening and testing, products manufactured using components of human blood such as ATGAM may carry a risk of transmitting infectious agents (e.g., viruses). Discuss the risks and benefits of therapy with patients before initiating treatment [see Warnings and Precautions (5.2)].

Infections

  • Advise the patient to discontinue ATGAM and report any sign/symptoms of leukopenia, thrombocytopenia, or infection (e.g., fever, sweating, chills, muscle aches, cough, shortness of breath, diarrhea or stomach pain) [see Warnings and Precautions (5.1), (5.2), (6)].

Prescribing information (PDF)

Open Prescribing information

Search

Find medical information documents that include ATGAM® and:

What's New

No Current Announcements.

Other Resources

Pfizer RxPathways – find information on prescription assistance programs for eligible patients
 
Pfizer Corporate Site
 
Pfizer News Channel on You Tube
 

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Other Resources

Pfizer RxPathways – find information on prescription assistance programs for eligible patients
 
Pfizer Corporate Site
 
Pfizer News Channel on You Tube
 

Contact Pfizer

Need to report an Adverse Event, Side Effect or Product Quality Concern?

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch

Have a Medical Question on a Pfizer Prescription Medicine?
Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985
Have a Question about Pfizer Clinical Trials?
If you are looking for information about Pfizer studies currently recruiting new patients in your area, you can begin your search on our website. For questions about a Pfizer Clinical Trial, call (800) 718-1021 or email [email protected]
Need Information on Pfizer’s Patient Assistance Programs?

Pfizer RxPathways® connects eligible patients, regardless of their insurance status, to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. For more information, please call (844) 989-7284 or visit www.PfizerRxPathways.com.

Eligible patients can register for valuable savings offers for nearly 40 brand name medications. Visit www.MyPfizerBrands.com for more information.